ਖ਼ਬਰਾਂ

Beyond helping diabetes patients lose weight and control blood sugar, semaglutide appears to cut dementia risk by nearly half ...
A massive U.S. study found diabetics on semaglutide (Ozempic’s active ingredient) had up to 70% lower risk of ...
A blockbuster diabetes and weight-loss drug might be doing more than controlling blood sugar—it could also be protecting the ...
Amanda Bynes Ozempic weight loss journey is making headlines as the former Nickelodeon star revealed plans to lose over 40 ...
All too often celebrities will tell a white lie when asked the secret to their new figure after drastic weight loss, but Amy ...
Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.
Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.
Diabetes drug Ozempic and weight-loss jab Wegovy may also reduce the risk of dementia, according to a new study. American ...
Wegovy is only approved for obesity in India. Novo Nordisk has no immediate plans to launch Ozempic for type 2 diabetes, ...
CHMP recommends approval of Novo Nordisk’s Ozempic for peripheral arterial disease: Bagsværd, Denmark Wednesday, June 25, 2025, 15:00 Hrs [IST] Novo Nordisk, a leading global h ...
Ozempic, a drug approved to treat type 2 diabetes, is an effective way to lose weight as well. Here's a list of celebrities ...
The once-monthly drug is still under study but could provide added convenience and another option for patients.